Study of GS-1219 in Participants With HIV-1
Stopped early · Phase 1
Conditions studied: HIV-1-infection
In brief
This study is part of a master study. The goal of master protocol (GSUS-544-5905, NCT05585307) is to learn how novel antiretrovirals (medicines that stop the virus from multiplying) affect the human immunodeficiency virus-1 (HIV-1) infection in people living with HIV (PWH). Substudy GS-US-544-5905-04 is to learn more about study drug GS-1219, safety, pharmacokinetics (PK) (how GS-1219 is absorbed, modified, distributed, and removed from the body of the participants), and antiviral activity in Participants With HIV-1.
Key facts
- Study ID
- NCT07115368
- Run by
- Gilead Sciences
- People needed
- 4
- Starts
- 2025-08-11
- Expected to finish
- 2025-10-02
- Last updated by the study team
- 2025-10-21
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ruane Clinical Research Group — Los Angeles, California, United States
- Mills Clinical Research — Los Angeles, California, United States
- Quest Clinical Research — San Francisco, California, United States
- Washington Health Institute — Washington D.C., District of Columbia, United States
- Midland Florida Clinical Research Center — DeLand, Florida, United States
- Midway Immunology and Research Center — Ft. Pierce, Florida, United States
- BLISS Health Inc — Orlando, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- Triple O Research Institute — West Palm Beach, Florida, United States
- Be Well Medical Center — Berkley, Michigan, United States
- Central Texas Clinical Research — Austin, Texas, United States
- Prism Health North Texas — Dallas, Texas, United States
- North Texas Infectious Diseases Consultants — Dallas, Texas, United States
- AXCES Research Group — El Paso, Texas, United States
- AXCES Research Group — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.